Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput Assays
- PMID: 27124219
- PMCID: PMC5783724
- DOI: 10.1021/acs.est.6b00374
Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput Assays
Abstract
The toxicity-testing paradigm has evolved to include high-throughput (HT) methods for addressing the increasing need to screen hundreds to thousands of chemicals rapidly. Approaches that involve in vitro screening assays, in silico predictions of exposure concentrations, and pharmacokinetic (PK) characteristics provide the foundation for HT risk prioritization. Underlying uncertainties in predicted exposure concentrations or PK behaviors can significantly influence the prioritization of chemicals, though the impact of such influences is unclear. In the current study, a framework was developed to incorporate absorbed doses, PK properties, and in vitro dose-response data into a PK/pharmacodynamic (PD) model to allow for placement of chemicals into discrete priority bins. Literature-reported or predicted values for clearance rates and absorbed doses were used in the PK/PD model to evaluate the impact of their uncertainties on chemical prioritization. Scenarios using predicted absorbed doses resulted in a larger number of bin misassignments than those scenarios using predicted clearance rates, when comparing to bin placement using literature-reported values. Sensitivity of parameters on the model output of toxicological activity was examined across possible ranges for those parameters to provide insight into how uncertainty in their predicted values might impact uncertainty in activity.
Conflict of interest statement
The authors declare the following competing financial interest(s): Daniel Chang is employed by the Chemical Computing Group in Montreal, Canada, the publisher of the Molecular Operating Environment (MOE) software.
Figures


References
-
- Abt E, Rodricks JV, Levy JI, Zeise L, Burke TA. Science and Decisions: Advancing Risk Assessment. Risk Anal. 2010;30(7):1028–1036. - PubMed
-
- Krewski D, Andersen ME, Mantus E, Zeise L. Toxicity testing in the 21st century: Implications for human health risk assessment. Risk Anal An Off Publ Soc Risk Anal. 2009;29(4):474–479. - PubMed
-
- Hau J, Schapiro SJ, Jr, GL VH. Handbook of Laboratory Animal Science: Animal Models. 2. CRC Press; Boca Raton: 2002.
-
- MacIntosh DL, Spengler JD, Gutschmidt K, Lyle K. Human Exposure Assessment; Environmental Health Criteria Monograph 214. International Programme on Chemical Safety; Geneva, Switzerland: 2000.
-
- Risk assessment forum white paper: Probabalistic risk assessment methods and case studies; Highlights of EPA/100/R-14/004. United States Environmental Protection Agency Office of the Science Advisor; Washington, DC: 2014. [15 Dec 2015]. http://www.epa.gov/sites/production/files/2014-12/documents/raf-pra-whit....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources